Flinton Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $193K | Sell |
5,280
-48
| -0.9% | -$1.76K | 0.01% | 677 |
|
|
2019
Q2 | $248K | Sell |
5,328
-1,392
| -21% | -$64.8K | 0.01% | 644 |
|
|
2019
Q1 | $270K | Buy |
6,720
+208
| +3% | +$8.36K | 0.01% | 617 |
|
|
2018
Q4 | $299K | Sell |
6,512
-1,328
| -17% | -$61K | 0.01% | 561 |
|
|
2018
Q3 | $348K | Buy |
7,840
+6,800
| +654% | +$302K | 0.01% | 598 |
|
|
2018
Q2 | $41K | Sell |
1,040
-9,056
| -90% | -$357K | ﹤0.01% | 818 |
|
|
2018
Q1 | $730K | Buy |
10,096
+7,648
| +312% | +$553K | 0.02% | 340 |
|
|
2017
Q4 | $161K | Sell |
2,448
-1,776
| -42% | -$117K | 0.01% | 696 |
|
|
2017
Q3 | $212K | Sell |
4,224
-512
| -11% | -$25.7K | 0.01% | 605 |
|
|
2017
Q2 | $219K | Sell |
4,736
-1,600
| -25% | -$74K | 0.01% | 558 |
|
|
2017
Q1 | $224K | Hold |
6,336
| – | – | 0.01% | 476 |
|
|
2016
Q4 | $79K | Buy |
+6,336
| New | +$79K | ﹤0.01% | 644 |
|